Literature DB >> 22634477

Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.

Bridgette M Collins-Burow1, James W Antoon, Daniel E Frigo, Steven Elliott, Christopher B Weldon, Stephen M Boue, Barbara S Beckman, Tyler J Curiel, Jawed Alam, John A McLachlan, Matthew E Burow.   

Abstract

Flavonoid phytochemicals act as both agonists and antagonists of the human estrogen receptors (ERs). While a number of these compounds act by directly binding to the ER, certain phytochemicals, such as the flavonoid compounds chalcone and flavone, elicit antagonistic effects on estrogen signaling independent of direct receptor binding. Here we demonstrate both chalcone and flavone function as cell type-specific selective ER modulators. In MCF-7 breast carcinoma cells chalcone and flavone suppress ERα activity through stimulation of the stress-activated members of the mitogen-activated protein kinase (MAPK) family: c-Jun N-terminal kinase (JNK)1 and JNK2. The use of dominant-negative mutants of JNK1 or JNK2 in stable transfected cells established that the antiestrogenic effects of chalcone and flavone required intact JNK signaling. We further show that constitutive activation of the JNK pathway partially suppresses estrogen (E2)-mediated gene expression in breast, but not endometrial carcinoma cells. Our results demonstrate a role for stress-activated MAPKs in the cell type-specific regulation of ERα function.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634477      PMCID: PMC4083692          DOI: 10.1016/j.jsbmb.2012.05.004

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  67 in total

1.  Bcl-2 is not reduced in the death of MCF-7 cells at low genistein concentration.

Authors:  L K Leung; T T Wang
Journal:  J Nutr       Date:  2000-12       Impact factor: 4.798

2.  Biomimetic syntheses and antiproliferative activities of racemic, natural (-), and unnnatural (+) glyceollin I.

Authors:  Rahul S Khupse; Jeffrey G Sarver; Jill A Trendel; Nicole R Bearss; Michael D Reese; Thomas E Wiese; Stephen M Boue; Matthew E Burow; Thomas E Cleveland; Deepak Bhatnagar; Paul W Erhardt
Journal:  J Med Chem       Date:  2011-04-22       Impact factor: 7.446

3.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

4.  Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.

Authors:  B M Collins-Burow; M E Burow; B N Duong; J A McLachlan
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

5.  The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway.

Authors:  P H Driggers; J H Segars; D M Rubino
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

Review 6.  The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses.

Authors:  M Rincón; R A Flavell; R A Davis
Journal:  Free Radic Biol Med       Date:  2000-05-01       Impact factor: 7.376

7.  Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics.

Authors:  James W Antoon; Jiawang Liu; Adharsh P Ponnapakkam; Matthew M Gestaut; Maryam Foroozesh; Barbara S Beckman
Journal:  Cancer Chemother Pharmacol       Date:  2010-02-14       Impact factor: 3.333

8.  Rho GTPases as modulators of the estrogen receptor transcriptional response.

Authors:  L F Su; R Knoblauch; M J Garabedian
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

9.  Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.

Authors:  Melyssa R Bratton; James W Antoon; Bich N Duong; Daniel E Frigo; Syreeta Tilghman; Bridgette M Collins-Burow; Steven Elliott; Yan Tang; Lilia I Melnik; Ling Lai; Jawed Alam; Barbara S Beckman; Steven M Hill; Brian G Rowan; John A McLachlan; Matthew E Burow
Journal:  J Endocrinol       Date:  2012-05-04       Impact factor: 4.286

10.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

View more
  6 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2013

Review 2.  Polyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits.

Authors:  David O Kennedy
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

3.  Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.

Authors:  Mamaru Bitew; Tegene Desalegn; Taye B Demissie; Anteneh Belayneh; Milkyas Endale; Rajalakshmanan Eswaramoorthy
Journal:  PLoS One       Date:  2021-12-10       Impact factor: 3.240

4.  Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.

Authors:  James W Antoon; Ashley M Nitzchke; Elizabeth C Martin; Lyndsay V Rhodes; Seungyoon Nam; Scott Wadsworth; Virgilo A Salvo; Steven Elliott; Bridgette Collins-Burow; Kenneth P Nephew; Matthew E Burow
Journal:  Int J Oncol       Date:  2013-02-08       Impact factor: 5.650

5.  Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway.

Authors:  Ruili Huang; Srilatha Sakamuru; Matt T Martin; David M Reif; Richard S Judson; Keith A Houck; Warren Casey; Jui-Hua Hsieh; Keith R Shockley; Patricia Ceger; Jennifer Fostel; Kristine L Witt; Weida Tong; Daniel M Rotroff; Tongan Zhao; Paul Shinn; Anton Simeonov; David J Dix; Christopher P Austin; Robert J Kavlock; Raymond R Tice; Menghang Xia
Journal:  Sci Rep       Date:  2014-07-11       Impact factor: 4.379

Review 6.  Polyphenols as Promising Drugs against Main Breast Cancer Signatures.

Authors:  María Losada-Echeberría; María Herranz-López; Vicente Micol; Enrique Barrajón-Catalán
Journal:  Antioxidants (Basel)       Date:  2017-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.